Multiple Sclerosis News Today Forums Forums Trials and Research Aubagio, Tecfidera are Comparable in Relapsing MS, Phase 4 Trial Finds

  • Aubagio, Tecfidera are Comparable in Relapsing MS, Phase 4 Trial Finds

    Posted by ms-news-today-moderator on March 15, 2019 at 11:44 am

    The effectiveness of Aubagio has been found to be superior to Tecfidera on whole brain atrophy in relapsing MS patients, yet similar for other MRI and clinical goals. Learn more about these findings here.

    What do you think of this trial and its findings?

    replied 5 years ago 1 Member · 0 Replies
  • 0 Replies

Sorry, there were no replies found.

Log in to reply.